P53 AND CATHEPSIN-D ARE INDEPENDENT OF ESTABLISHED PROGNOSTIC FACTORS IN BREAST-CANCER

被引:0
作者
SILVESTRINI, R [1 ]
VENERONI, S [1 ]
BENINI, E [1 ]
DIFRONZO, G [1 ]
DAIDONE, MG [1 ]
机构
[1] CNR,CTR STUDIO PATOL CELLULARE,I-20133 MILAN,ITALY
关键词
P53; CATHEPSIN-D; PROLIFERATIVE ACTIVITY; PLOIDY; STEROID RECEPTORS; BIOLOGIC CHARACTERIZATION; BREAST CANCER;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
p53 and cathepsin D expression was investigated in 300 primary breast cancers by the avidin-biotin immunoperoxidase method using two murine monoclonal antibodies: PAb1801 and anti-procathepsin D, respectively. The frequency of p53- and cathepsin D-positive cells varied widely among different tumors and most tumors (82% and 86%) at least occasionally showed positive cells. The two biological markers were unrelated to one another, to cell proliferative rate and ploidy and were differently related to other biological and pathological features. In particular, p53 was directly related to tumor size and nodal involvement and inversely related to the presence of steroid receptors. Conversely, cathepsin D was directly related only to nodal involvement.
引用
收藏
页码:507 / 512
页数:6
相关论文
共 50 条
[1]   GENETIC ALTERATIONS IN PRIMARY BREAST-CANCER [J].
CALLAHAN, R .
BREAST CANCER RESEARCH AND TREATMENT, 1989, 13 (03) :191-203
[2]  
CAMPO E, 1991, CANCER RES, V51, P4436
[3]   P53 EXPRESSION IN BREAST-CANCER [J].
CATTORETTI, G ;
RILKE, F ;
ANDREOLA, S ;
DAMATO, L ;
DELIA, D .
INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (02) :178-183
[4]   LOSS OF HETEROZYGOSITY ON THE SHORT ARM OF CHROMOSOME-17 IS ASSOCIATED WITH HIGH PROLIFERATIVE CAPACITY AND DNA ANEUPLOIDY IN PRIMARY HUMAN BREAST-CANCER [J].
CHEN, LC ;
NEUBAUER, A ;
KURISU, W ;
WALDMAN, FM ;
LJUNG, BM ;
GOODSON, W ;
GOLDMAN, ES ;
MOORE, D ;
BALAZS, M ;
LIU, E ;
MAYALL, BH ;
SMITH, HS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (09) :3847-3851
[5]   PREDICTION OF RELAPSE OR SURVIVAL IN PATIENTS WITH NODE-NEGATIVE BREAST-CANCER BY DNA FLOW-CYTOMETRY [J].
CLARK, GM ;
DRESSLER, LG ;
OWENS, MA ;
POUNDS, G ;
OLDAKER, T ;
MCGUIRE, WL .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (10) :627-633
[6]   PROGNOSTIC-SIGNIFICANCE OF S-PHASE FRACTION IN GOOD-RISK, NODE-NEGATIVE BREAST-CANCER PATIENTS [J].
CLARK, GM ;
MATHIEU, MC ;
OWENS, MA ;
DRESSLER, LG ;
EUDEY, L ;
TORMEY, DC ;
OSBORNE, CK ;
GILCHRIST, KW ;
MANSOUR, EG ;
ABELOFF, MD ;
MCGUIRE, WL .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (03) :428-432
[7]   DNA PLOIDY AND SURVIVAL IN BREAST-CANCER PATIENTS [J].
CORNELISSE, CJ ;
VANDEVELDE, CJH ;
CASPERS, RJC ;
MOOLENAAR, AJ ;
HERMANS, J .
CYTOMETRY, 1987, 8 (02) :225-234
[8]   FACTORS AFFECTING RELAPSE IN NODE-NEGATIVE BREAST-CANCER - A MULTIVARIATE-ANALYSIS INCLUDING THE LABELING INDEX [J].
COURDI, A ;
HERY, M ;
DAHAN, E ;
GIOANNI, J ;
ABBES, M ;
MONTICELLI, J ;
ETTORE, F ;
MOLL, JL ;
NAMER, M .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (02) :351-356
[9]   LAMININ RECEPTORS, COLLAGENASE-IV AND PROGNOSIS IN NODE-NEGATIVE BREAST CANCERS [J].
DAIDONE, MG ;
SILVESTRINI, R ;
DERRICO, A ;
DIFRONZO, G ;
BENINI, E ;
MANCINI, AM ;
GARBISA, S ;
LIOTTA, LA ;
GRIGIONI, WF .
INTERNATIONAL JOURNAL OF CANCER, 1991, 48 (04) :529-532
[10]   GENETIC-BASIS FOR P53 OVEREXPRESSION IN HUMAN BREAST-CANCER [J].
DAVIDOFF, AM ;
HUMPHREY, PA ;
IGLEHART, JD ;
MARKS, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (11) :5006-5010